Codes / ICD10CM / H02.886

H02.886 Meibomian gland dysfunction of left eye, unspecified eyelid

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Meibomian Gland Dysfunction of Left Eye, Unspecified Eyelid

Summary

Meibomian gland dysfunction (MGD) is a condition affecting the meibomian glands in the eyelids, which produce the oily layer of the tear film. When this dysfunction occurs in the left eye, it can lead to dry, irritated eyes due to inadequate lubrication of the ocular surface.

Causes

MGD is primarily caused by blockages or structural changes in the meibomian glands. These changes may result from aging, hormonal imbalances, chronic inflammation, or underlying skin conditions like rosacea. Abnormal secretion or thickening of glandular secretions can also contribute to the condition.

Risk Factors

  • Aging, as gland function tends to decline with time.
  • Hormonal fluctuations, particularly in post-menopausal individuals.
  • History of inflammatory skin conditions, such as rosacea or seborrheic dermatitis.
  • Use of contact lenses or certain medications that affect tear production.
  • Prolonged screen time, which reduces blink rate and may exacerbate symptoms.

Symptoms

  • Dryness, irritation, or a gritty sensation in the eyes.
  • Blurred vision or sensitivity to light.
  • Redness, swelling, or inflammation of the eyelids.
  • Excessive tearing or crusting along the eyelid margins.
  • Discomfort or burning sensation, especially upon waking.

Diagnosis

Diagnosis is typically based on a clinical evaluation of the eyelids and tear film, including assessment of gland structure and secretion quality. Slit-lamp examination and meibomian gland expression may be performed to confirm the presence of blockages or abnormal secretions.

Treatment Options

Treatment focuses on relieving symptoms and improving gland function. Options include warm compresses, eyelid hygiene, artificial tears, and prescription medications such as anti-inflammatory drops or antibiotics. In some cases, procedures like meibomian gland expression or intense pulsed light therapy may be recommended.

Prognosis and Follow-Up

Prognosis varies depending on the severity and underlying causes of the dysfunction. With consistent treatment, many patients experience symptom relief. Regular follow-up is important to monitor gland function and adjust therapy as needed.

Complications

Untreated MGD can lead to chronic dry eye, corneal irritation, or increased risk of eye infections. Severe cases may result in permanent damage to the ocular surface.

Lifestyle & Prevention

  • Maintain good eyelid hygiene with regular cleaning.
  • Use warm compresses to help unclog glands.
  • Avoid prolonged screen time and take breaks to reduce eye strain.
  • Stay hydrated and manage underlying conditions like rosacea.

When to Seek Professional Help

Seek care if symptoms persist despite home care, worsen over time, or are accompanied by vision changes, severe pain, or signs of infection (e.g., discharge, increased redness).

Tips for Medical Coders

Document the specific eyelid (left eye, unspecified) and confirm the diagnosis aligns with clinical findings. Ensure the code H02.886 is used when the condition is localized to the left eye without specifying the upper or lower eyelid.

Book a walkthrough

H02.886 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.